Evenity 105 mg/1.17 mL
Evenity 105 mg/1.17 mL Evenity 105 mg/1.17 mL contains romosozumab, a monoclonal antibody used to treat osteoporosis in people who have a high risk of fractures. It helps strengthen bones through a dual action—encouraging the body to form new bone while reducing the breakdown of existing bone. Each syringe contains 105 mg of romosozumab, and two syringes are required to provide the complete 210 mg monthly dose. It is given as a subcutaneous injection by a healthcare professional.
| Brand | Evenity |
| Storage Temperature | 2°C to 8°C |
| Prescription Needed | Yes |
| Composition | Romosozumab |
| Strength | 105 mg/1.17 mL per syringe |
| Form | Solution for Injection |
| Pack Size | 2 × 105 mg/1.17 mL Prefilled Syringes |
| Packaging | Single-Use Prefilled Syringe |
| Manufacturer | Amgen |
Evenity 105 mg/1.17 mL
Evenity 105 mg/1.17 mL Evenity 105 mg/1.17 mL contains romosozumab, a monoclonal antibody used to treat osteoporosis in people who have a high risk of fractures. It helps strengthen bones through a dual action—encouraging the body to form new bone while reducing the breakdown of existing bone. Each syringe contains 105 mg of romosozumab, and two syringes are required to provide the complete 210 mg monthly dose. It is given as a subcutaneous injection by a healthcare professional.
